Zydus Lifesciences shares hit record high after better-than-expected Q4 FY24 results

Zydus Lifesciences (ZYDUSLIFE) shares scaled a record high in a special trading session on Saturday, May 18, after the drug maker reported a set of earnings that exceeded analysts' expectations. Around 11:45 am, the stock of Ahmedabad-headquartered Zydus Lifesciences was locked in the five per cent upper circuit at Rs 1,104.5 apiece on BSE. 

Minutes after the closing bell on Dalal Street on Friday, Zydus Lifesciences reported a nearly four times year-on-year jump in net profit to Rs 1,182 crore for the January-March period. 

Its quarterly margin improved by 440 basis points to 29.5 per cent, according to a regulatory filing.  

According to Zee Business research, Zydus Lifesciences' March-quarter net profit was estimated at Rs 920 crore and margin at 28.6 per cent. 

(This story will be updated shortly) 

Catch all the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.